• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Biomarker-guided classification scheme of neurodegenerative diseases.

作者信息

Baldacci Filippo, Lista Simone, Garaci Francesco, Bonuccelli Ubaldo, Toschi Nicola, Hampel Harald

机构信息

Department of Clinical and Experimental Medicine, University of Pisa, Pisa 56126, Italy.

Institute of Memory and Alzheimer's Disease (IM2A), Brain and Spine Institute (ICM) UMR S 1127, Department of Neurology, Pitié-Salpêtrière Hospital, Paris 75651, France.

出版信息

J Sport Health Sci. 2016 Dec;5(4):383-387. doi: 10.1016/j.jshs.2016.08.007. Epub 2016 Aug 23.

DOI:10.1016/j.jshs.2016.08.007
PMID:30356557
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6188916/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3666/6188916/e71382b0ee87/jshs321-fig-0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3666/6188916/e71382b0ee87/jshs321-fig-0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3666/6188916/e71382b0ee87/jshs321-fig-0001.jpg

相似文献

1
Biomarker-guided classification scheme of neurodegenerative diseases.神经退行性疾病的生物标志物导向分类方案。
J Sport Health Sci. 2016 Dec;5(4):383-387. doi: 10.1016/j.jshs.2016.08.007. Epub 2016 Aug 23.
2
Diagnostic function of the neuroinflammatory biomarker YKL-40 in Alzheimer's disease and other neurodegenerative diseases.神经炎症生物标志物YKL-40在阿尔茨海默病及其他神经退行性疾病中的诊断功能
Expert Rev Proteomics. 2017 Apr;14(4):285-299. doi: 10.1080/14789450.2017.1304217. Epub 2017 Mar 20.
3
Molecular Pathological Classification of Neurodegenerative Diseases: Turning towards Precision Medicine.神经退行性疾病的分子病理分类：迈向精准医学
Int J Mol Sci. 2016 Feb 2;17(2):189. doi: 10.3390/ijms17020189.
4
Proposed new classification scheme for chemical injury to the human eye.人类眼部化学伤的拟议新分类方案。
Regul Toxicol Pharmacol. 2006 Jul;45(2):206-13. doi: 10.1016/j.yrtph.2006.04.005. Epub 2006 Jun 9.
5
Ethical considerations of biomarker use in neurodegenerative diseases--a case study of Alzheimer's disease.生物标志物在神经退行性疾病中的应用的伦理考虑——以阿尔茨海默病为例。
Prog Neurobiol. 2011 Dec;95(4):517-9. doi: 10.1016/j.pneurobio.2011.11.009. Epub 2011 Nov 22.
6
Reliable computer-assisted classification of the EEG: EEG variants in index cases and their first degree relatives.脑电图的可靠计算机辅助分类：索引病例及其一级亲属中的脑电图变异
Am J Med Genet. 1996 Feb 16;67(1):1-8. doi: 10.1002/(SICI)1096-8628(19960216)67:1<1::AID-AJMG1>3.0.CO;2-W.
7
Assessment of translational risk in drug research: Role of biomarker classification and mechanism-based PKPD concepts.药物研究中翻译风险的评估：生物标志物分类和基于机制的 PKPD 概念的作用。
Eur J Pharm Sci. 2017 Nov 15;109S:S72-S77. doi: 10.1016/j.ejps.2017.08.006. Epub 2017 Aug 13.
8
Developing a contributing factor classification scheme for Rasmussen's AcciMap: Reliability and validity evaluation.为拉斯穆森事故映射图制定影响因素分类方案：可靠性与有效性评估
Appl Ergon. 2017 Oct;64:14-26. doi: 10.1016/j.apergo.2017.04.014. Epub 2017 May 8.
9
Based on the Network Degeneration Hypothesis: Separating Individual Patients with Different Neurodegenerative Syndromes in a Preliminary Hybrid PET/MR Study.基于网络退化假说：在一项初步的混合PET/MR研究中区分患有不同神经退行性综合征的个体患者。
J Nucl Med. 2016 Mar;57(3):410-5. doi: 10.2967/jnumed.115.165464. Epub 2015 Nov 19.
10
Diagnostic accuracy of CSF neurofilament light chain protein in the biomarker-guided classification system for Alzheimer's disease.脑脊液神经丝轻链蛋白在阿尔茨海默病生物标志物导向分类系统中的诊断准确性。
Neurochem Int. 2017 Sep;108:355-360. doi: 10.1016/j.neuint.2017.05.010. Epub 2017 May 17.

引用本文的文献

1
Fluid Candidate Biomarkers for Alzheimer's Disease: A Precision Medicine Approach.阿尔茨海默病的潜在生物标志物：精准医学方法
J Pers Med. 2020 Nov 11;10(4):221. doi: 10.3390/jpm10040221.
2
The path to biomarker-based diagnostic criteria for the spectrum of neurodegenerative diseases.基于生物标志物的神经退行性疾病谱的诊断标准的建立。
Expert Rev Mol Diagn. 2020 Apr;20(4):421-441. doi: 10.1080/14737159.2020.1731306. Epub 2020 Feb 27.
3
High Levels of -Amyloid, Tau, and Phospho-Tau in Red Blood Cells as Biomarkers of Neuropathology in Senescence-Accelerated Mouse.

本文引用的文献

1
A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers.A/T/N：阿尔茨海默病生物标志物的无偏描述性分类方案。
Neurology. 2016 Aug 2;87(5):539-47. doi: 10.1212/WNL.0000000000002923. Epub 2016 Jul 1.
2
The Prevalence and Incidence of Dementia Due to Alzheimer's Disease: a Systematic Review and Meta-Analysis.阿尔茨海默病所致痴呆的患病率和发病率：一项系统评价和荟萃分析。
Can J Neurol Sci. 2016 Apr;43 Suppl 1:S51-82. doi: 10.1017/cjn.2016.36.
3
Toward precision medicine in Alzheimer's disease.迈向阿尔茨海默病的精准医学。
衰老加速小鼠红细胞中高水平的β-淀粉样蛋白、tau 蛋白和磷酸化 tau 蛋白作为神经病理学的生物标志物。
Oxid Med Cell Longev. 2019 Jun 9;2019:5030475. doi: 10.1155/2019/5030475. eCollection 2019.
4
Potential Diagnostic Value of Red Blood Cells α-Synuclein Heteroaggregates in Alzheimer's Disease.红细胞α-突触核蛋白杂合体在阿尔茨海默病中的潜在诊断价值。
Mol Neurobiol. 2019 Sep;56(9):6451-6459. doi: 10.1007/s12035-019-1531-4. Epub 2019 Mar 2.
5
Current state of Alzheimer's fluid biomarkers.阿尔茨海默病的体液生物标志物现状。
Acta Neuropathol. 2018 Dec;136(6):821-853. doi: 10.1007/s00401-018-1932-x. Epub 2018 Nov 28.
6
α-Synuclein Heterocomplexes with β-Amyloid Are Increased in Red Blood Cells of Parkinson's Disease Patients and Correlate with Disease Severity.帕金森病患者红细胞中与β-淀粉样蛋白形成的α-突触核蛋白异源复合物增加，并与疾病严重程度相关。
Front Mol Neurosci. 2018 Feb 22;11:53. doi: 10.3389/fnmol.2018.00053. eCollection 2018.
7
Precision pharmacology for Alzheimer's disease.阿尔茨海默病的精准药理学。
Pharmacol Res. 2018 Apr;130:331-365. doi: 10.1016/j.phrs.2018.02.014. Epub 2018 Feb 16.
8
α-Synuclein Aggregated with Tau and β-Amyloid in Human Platelets from Healthy Subjects: Correlation with Physical Exercise.α-突触核蛋白与健康受试者人血小板中的 Tau 蛋白和β-淀粉样蛋白聚集：与体育锻炼的相关性。
Front Aging Neurosci. 2018 Jan 30;10:17. doi: 10.3389/fnagi.2018.00017. eCollection 2018.
9
Physical activity and prevention of Alzheimer's disease.身体活动与阿尔茨海默病的预防
J Sport Health Sci. 2016 Dec;5(4):381-382. doi: 10.1016/j.jshs.2016.10.008. Epub 2016 Nov 3.
10
PRECISION MEDICINE - The Golden Gate for Detection, Treatment and Prevention of Alzheimer's Disease.精准医学——检测、治疗和预防阿尔茨海默病的黄金大门。
J Prev Alzheimers Dis. 2016 Dec;3(4):243-259. doi: 10.14283/jpad.2016.112. Epub 2016 Sep 6.
Ann Transl Med. 2016 Mar;4(6):107. doi: 10.21037/atm.2016.03.05.
4
Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria.临床前阿尔茨海默病：定义、自然史及诊断标准。
Alzheimers Dement. 2016 Mar;12(3):292-323. doi: 10.1016/j.jalz.2016.02.002.
5
Alzheimer's disease.阿尔茨海默病。
Lancet. 2016 Jul 30;388(10043):505-17. doi: 10.1016/S0140-6736(15)01124-1. Epub 2016 Feb 24.
6
Molecular Pathological Classification of Neurodegenerative Diseases: Turning towards Precision Medicine.神经退行性疾病的分子病理分类：迈向精准医学
Int J Mol Sci. 2016 Feb 2;17(2):189. doi: 10.3390/ijms17020189.
7
Vascular dementia.血管性痴呆。
Lancet. 2015 Oct 24;386(10004):1698-706. doi: 10.1016/S0140-6736(15)00463-8.
8
Lewy body dementias.路易体痴呆症
Lancet. 2015 Oct 24;386(10004):1683-97. doi: 10.1016/S0140-6736(15)00462-6.
9
Frontotemporal dementia.额颞叶痴呆
Lancet. 2015 Oct 24;386(10004):1672-82. doi: 10.1016/S0140-6736(15)00461-4.
10
Parkinson's disease.帕金森病。
Lancet. 2015 Aug 29;386(9996):896-912. doi: 10.1016/S0140-6736(14)61393-3. Epub 2015 Apr 19.